Concept - Product - Mission
Concept
Product
Mission
About Us
We specialize in neuromodulation technologies for the peripheral nervous system. We are developing a product to restore lost functionalities of people with damages to the peripheral nerves, or dysfunctions that can be treated by stimulating the peripheral nerves.
OUR PRESENTATION
Sponsors, awards and prizes
AWARDS and prizes
Latest News
Check out our latest news and stories
Our CEO, Francesco Petrini, was nominated among the 35 innovators under 35, from MIT
Although orthopaedics are already highly mobile, they cannot replicate the feeling of having a real leg. To address this problem, SensArs Neuroprosthetics founder, Francesco Petrini, has developed SENSY.
SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY
SensArs Neuroprosthetics coordinates a 3 million EUR grant to develop and test its product that restores life-like sensations from the prosthesis of leg amputees SensArs Neuroprosthetics announces the start of a project financed by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 870144. The European Commission will give a[…]
SensArs financed from the European Commission to explore the feasibility of stimulating the vagal nerve
SensArs, within a consortium of 6 partners coming from 5 countries, was financed from the European Commission to explore the feasibility of stimulating the vagal nerve to control the heartbeat of patients who underwent heart transplantation. The project is called NeuHearth (Grant agreement ID: 824071). More information can be found here.
SensArs among the successful stories mentioned by the EIT Health
SensArs among the successful stories mentioned by the EIT Health. Check the link
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018
SensArs is one of the 4 Startups selected for the EIT Health Germany Headstart Awards 2018 – valued at €50,000 each – to accelerate their entry to market. Read here the news from EIT Health.
SensArs among the successful stories mentioned by the European Commission
SensArs among the successful stories mentioned by the European Commission. Check the link
SensArs project is recommended for funding by European Commission
Click here to view full document.
Ten start-ups selected for the venture leaders Life Science program in Boston
“The venture leaders Life Science program is a one-week investors and business roadshow in Boston, co-organized with swissnex Boston. This year’s winners develop amazing technologies such as a prosthesis which allows amputees to naturally feel their missing limbs again or an ingeniously simple approach to computed guided needle navigation in the body.”
SensArs listed as one of best 100 Swiss startups
“The seventh edition of the TOP 100 Swiss startup ranking was disclosed on September 6th in front of 600 participants. The broad spectrum of innovative high-tech startups attracted dozens of investors from abroad, and even from Silivon Valley and China. Switzerland ranks as the most innovative nation according to the Global Innovation Index 2017. The TOP[…]
Swiss start-ups receive financial support from Horizon 2020 SME instrument
‘Four Swiss start-ups will receive CHF 50’000 each through the Horizon 2020 SME instrument scheme. The instrument, provided with about € 3 billion, is accessible to Swiss SMEs since January 2017. Next application deadline is 6 September.’